37 results
10-K
2022 FY
EX-4.6
BLCM
Bellicum Pharmaceuticals, Inc
Annual report
31 Mar 23
4:03pm
S-3
EX-4.3
BLCM
Bellicum Pharmaceuticals, Inc
Shelf registration
13 May 22
4:09pm
S-3
EX-4.5
BLCM
Bellicum Pharmaceuticals, Inc
Shelf registration
13 May 22
4:09pm
S-3
EX-4.7
BLCM
Bellicum Pharmaceuticals, Inc
Shelf registration
13 May 22
4:09pm
S-3
EX-4.6
BLCM
Bellicum Pharmaceuticals, Inc
Shelf registration
13 May 22
4:09pm
8-K
EX-4.1
y907gx6vrwpdlni
6 Dec 21
Entry into a Material Definitive Agreement
8:30am
8-K
EX-4.2
2af794vwo6pno
6 Dec 21
Entry into a Material Definitive Agreement
8:30am
8-K
EX-4.1
1m7gu79vviq5hblgs am
2 Nov 20
Bellicum Announces $25.0 Million Underwritten Offering Priced At-The-Market
6:06am
8-K
EX-4.2
7100b6k dhq1bn0h
2 Nov 20
Bellicum Announces $25.0 Million Underwritten Offering Priced At-The-Market
6:06am
8-K
EX-4.1
9jt0k1v2j264x5kd
19 Aug 19
Bellicum Pharmaceuticals Announces Proposed $53.0 Million Public Offering of Preferred Stock and Warrants with Concurrent Private Placement
5:27pm
8-K
EX-4.2
48h39scbuqv
19 Aug 19
Bellicum Pharmaceuticals Announces Proposed $53.0 Million Public Offering of Preferred Stock and Warrants with Concurrent Private Placement
5:27pm